Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2013

May 21, 2013

30071_dirs_2013-05-21_e41ae380-58cf-4171-8e95-eb4ff6153371.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-05-17

Reporting Person: ROBERTS CHRISTOPHER G (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-05-17 ResMed Common Stock M 12000 $23.095 Acquired 42000 Direct
2013-05-17 ResMed Common Stock M 48000 $12.738 Acquired 90000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-05-17 ResMed Stock Options $23.095 M 12000 Disposed 2013-11-10 ResMed Common Stock (12000) Direct
2013-05-17 ResMed Stock Options $12.738 M 48000 Disposed 2014-07-02 ResMed Common Stock (48000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 272400 Indirect
ResMed Common Stock 23200 Indirect
ResMed Common Stock 136000 Indirect

Footnotes

F1: Represents date options first became exercisable. Options vest 1/12 each month until fully vested.

F2: Represents date first became exercisable. Options vest 1/3 each year on the anniversary of the grant.